Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-10-14

FDA Approved: BENZTROPINE MESYLATE — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved the original application for benztropine mesylate (generic) from Hikma Pharmaceuticals USA Inc., for use in treating Parkinsonism and reversible ex…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Benztropine Mesylate (benztropine mesylate)

Snippet

ORIG AP for BENZTROPINE MESYLATE (BENZTROPINE MESYLATE)